Five (FRRS1, CTRAM, SCGB3A1, FAM92B/CIBAR2, and TMEFF2) of the top 20 genes were ranked the most significant distinctions between AD samples vs. control. This evidence concerns the gene CIBAR2 and Alzheimer disease.